CompanyPrivateMclean, VA

Retension Pharmaceuticals, Inc

SEC EDGAR ClinicalTrials.gov

8-KOct 23Latest SEC filing, period to Oct 21

Form DMay 6$12M sold

October 2026

Retension Pharmaceuticals names Robert Wong chief accounting officer

Oct 22PeopleRetension Pharmaceuticals, Inc

Beyond Air preannounces $2.3 million revenue, reaffirms 2026 and 2027 guidance

Oct 9Quarterly updateBeyond Air, Inc Retension Pharmaceuticals, IncUpdated